Home » Topics » Disease categories and therapies » Urology

Urology
RSS

OxThera receives financing to continue key clinical programs

April 17, 2014

Prevention of PGE2-induced bladder overactivity by TRPM8 blocker DFL-23448

April 17, 2014

French team presents novel V2 receptor antagonist peptides

April 10, 2014

EMA validates Keryx Biopharmaceuticals' MAA for Zerenex

April 3, 2014

AM-Pharma reports phase I data for recombinant human alkaline phosphatase

March 31, 2014

Enrollment begins in phase III study of ZS-9 in patients with hyperkalemia

March 28, 2014

Dimerix Bioscience raises funds to advance DMX-200

March 28, 2014

Samsca approved in Japan for autosomal dominant polycystic kidney disease

March 26, 2014

Ipsen reports findings from phase IIa study of Dysport for neurogenic detrusor overactivity

March 19, 2014

Novel spirocyclic diamine derivatives with activity in animal models of CKD

March 17, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...